Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Pentagon approves 20 more military coronavirus vaccination teams

Pentagon spokesman John Kirby. Photo: Yasin Ozturk/Anadolu Agency via Getty Images

The Pentagon has approved the deployment of 20 additional COVID-19 vaccination teams to aid inoculation efforts across the U.S., spokesperson John Kirby said Friday.

The big picture: The authorization brings the number of approved vaccination teams to 25, with a total of about 4,700 service members, Kirby told reporters.

  • Only one team of 222 service members has deployed so far. Those troops, which begin work on Monday, will help a federally run vaccination site at California State University.
  • The Pentagon will soon have more details on when and where the four other previously approved teams will be deployed, Kirby said.
  • The vaccination teams "are being organized to help FEMA-identified sites and will be deployed as requirements evolve," he added.

Worth noting: FEMA's full request was for 10,000 troops to be deployed to 100 vaccination sites.

  • “I want to stress the very deliberate and phased approach we’re taking — working in lockstep with FEMA and other federal authorities … What we’re trying to do is to be ready when we’re needed.," Kirby said.

Go deeper: Biden blasts Trump's vaccination efforts

Go deeper

Jacob Knutson
Feb 11, 2021 - Health

Biden administration purchases 200 million additional vaccine doses

President Biden in the Oval Office of the White House on Feb. 11. Photo: Doug Mills/The New York Times/Bloomberg via Getty Images

The federal government purchased an additional 200 million doses of the coronavirus vaccine, President Biden announced Thursday during a tour of the National Institutes of Health.

The big picture: Biden said the U.S. is on track to have enough supply of the vaccine to inoculate 300 million Americans by the end of July. That comes out to roughly 600 million doses, boosting "supply in the United States by 50 percent," as first reported by the Washington Post.

Go deeper (1 min. read)Arrow
Axios
Feb 12, 2021 - Politics & Policy

Biden blasts Trump's COVID vaccination efforts: "Did not do his job"

President Biden. Photo: Oliver Contreras/Sipa/Bloomberg via Getty Images

President Biden on Thursday slammed his predecessor for "not doing his job in getting ready for the massive challenge of vaccinating hundreds of millions of Americans."

Driving the news: Biden's remarks at the National Institutes of Health came not long after his administration signed final contracts with Pfizer and Moderna to purchase an additional 200 million doses of the coronavirus vaccines.

Go deeper (1 min. read)Arrow
Joann Muller, Alison Snyder
Feb 12, 2021 - Health

Why vaccine production is taking so long

Illustration: Eniola Odetunde/Axios

COVID-19 vaccine makers are under intense pressure to rev up production, but the scale of the challenge is unprecedented — and the speed of production is limited.

Why it matters: Even with help from the federal government and outside companies, vaccine-making is a complex, time-consuming biological process. That limits how quickly companies like Pfizer and Moderna can accelerate their output even during a crisis.

Go deeper (3 min. read)Arrow

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!